Evogene Ltd. - Ordinary Shares (EVGN): Price and Financial Metrics

Evogene Ltd. - Ordinary Shares (EVGN): $0.74

0.03 (-4.11%)

POWR Rating

Component Grades








Add EVGN to Watchlist
Sign Up

Industry: Agriculture




#24 of 25

in industry

EVGN Price/Volume Stats

Current price $0.74 52-week high $1.44
Prev. close $0.78 52-week low $0.45
Day low $0.74 Volume 63,500
Day high $0.78 Avg. volume 179,810
50-day MA $0.81 Dividend yield N/A
200-day MA $0.78 Market Cap 30.64M

EVGN Stock Price Chart Interactive Chart >

Evogene Ltd. - Ordinary Shares (EVGN) Company Bio

Evogene Ltd. operates as a plant genomics company that uses a technology infrastructure to enhance seed traits underlying crop productivity. The company was founded in 1999 and is based in Rehovot, Israel.

EVGN Latest News Stream

Event/Time News Detail
Loading, please wait...

EVGN Latest Social Stream

Loading social stream, please wait...

View Full EVGN Social Stream

Latest EVGN News From Around the Web

Below are the latest news stories about EVOGENE LTD that investors may wish to consider to help them evaluate EVGN as an investment opportunity.

Biomica CEO Set to Attend JP Morgan Healthcare Week in San Francisco, January 8-11, 2024

Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), is gearing up for participation in the JP Morgan 42nd Annual Healthcare Week, scheduled to run from January 8 to 11, 2024, in San Francisco. Biomica will also be taking part in the Biotech Showcase conference.

Yahoo | December 21, 2023

Casterra Appoints New CEO and Expands Team to Drive Growth and Innovation

Casterra Ag Ltd., a subsidiary of Evogene Ltd. ("Evogene") (Nasdaq: EVGN) (TASE: EVGN) and an integrated castor cultivation solution company for the bio-based industries (e.g. biofuels, biopolymers), today announced the appointment of Mr. Yoash Zohar as new CEO, as of January 1, 2024, to lead the company's expansion efforts. Considering Casterra's rapid growth and its continued prospects for development, this nomination aims to strengthen its leadership and positioning in the industry.

Yahoo | December 19, 2023

Is Compugen (CGEN) Outperforming Other Medical Stocks This Year?

Here is how Compugen (CGEN) and Evogene (EVGN) have performed compared to their sector so far this year.

Yahoo | December 5, 2023

Lavie Bio Announces a Distribution Agreement with WinField United Canada for its Bio-Inoculant Seed Treatment Yalos™

Lavie Bio Ltd., a subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading ag-biologicals company that develops microbiome-based, computational-driven bio-stimulant and bio-pesticide novel products, today announced a distribution agreement exclusive to independent retail with WinField United Canada for its bio-inoculant seed treatment Yalos™. This partnership aims to support Lavie Bio's 2024 sales growth strategy in Canada, with a focus on key agricultural regions, including Saskatchewa

Yahoo | December 5, 2023

Bears are Losing Control Over Evogene (EVGN), Here's Why It's a 'Buy' Now

After losing some value lately, a hammer chart pattern has been formed for Evogene (EVGN), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

Yahoo | November 29, 2023

Read More 'EVGN' Stories Here

EVGN Price Returns

1-mo -3.96%
3-mo -21.11%
6-mo 58.09%
1-year 23.95%
3-year -83.74%
5-year -67.83%
YTD -11.90%
2023 20.00%
2022 -57.32%
2021 -65.11%
2020 209.21%
2019 -23.23%

Continue Researching EVGN

Want to see what other sources are saying about Evogene Ltd's financials and stock price? Try the links below:

Evogene Ltd (EVGN) Stock Price | Nasdaq
Evogene Ltd (EVGN) Stock Quote, History and News - Yahoo Finance
Evogene Ltd (EVGN) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!